The enactment of HB598 will directly affect insurance policies operating in Hawaii by mandating that they provide these essential health services without imposing additional costs on the insured. Specifically, the bill is designed to enhance access to early detection and treatment of breast cancer, which is crucial for improving health outcomes. The prohibition on cost-sharing aims to remove financial barriers, making it more likely that individuals will seek necessary screenings and examinations in a timely manner, potentially leading to earlier diagnoses and better prognoses for affected patients.
House Bill 598, introduced in the 33rd Legislature of Hawaii in 2025, aims to prohibit cost-sharing requirements for specific breast cancer-related examinations and screenings under health insurance policies. This legislation is focused on ensuring that individuals insured under plans that provide coverage for breast cancer screening, supplemental breast examinations, and diagnostic breast examinations do not incur expenses such as deductibles, copayments, or coinsurance for these services. The bill takes into consideration individuals under high deductible health plans, allowing for the minimal cost-sharing necessary to maintain their eligibility under federal tax regulations.
While the bill has broad support as a means to improve women's health care access, there may be contention surrounding its implications for insurance premiums and the operational costs for insurers. Some stakeholders may argue that removing cost-sharing requirements could lead to increased insurance premiums for all policyholders as insurers adjust their pricing strategies to absorb the costs associated with covering these examinations without a copay. The bill's supporters emphasize the importance of prioritizing women's health over potential increased insurance costs, while opponents may raise concerns regarding the overall sustainability of such mandates on health insurance providers.